This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Modest Moves in the Big Indexes During the Week, but Still Plenty of Action
by David Borun
The broad markets ended slightly higher during a holiday-shortened week, but two high profile IPOs were the big story
Medicare-for-All, Mueller Report Spell Danger: 5 Utility Picks
by Swarup Gupta
Superior dividend yields and steady revenues make utilities good choices in tough times.
HCA Healthcare's Organic & Inorganic Strategies Drive Growth
by Zacks Equity Research
A number of acquisitions, network expansion, technological investment and strong balance sheet drive growth at HCA Healthcare (HCA).
HCA Healthcare to Buy Large Stake in Galen College of Nursing
by Zacks Equity Research
HCA Healthcare (HCA) to purchase the majority interest in Galen College of Nursing for boosting access to nursing education.
Is HCA Healthcare (HCA) a Worthy Pick for Value Investors?
by Zacks Equity Research
HCA Healthcare (HCA) stock may be a good choice for value-oriented investors right now from multiple angles.
Stock Market News For Mar 7, 2019
by Zacks Equity Research
Benchmarks ended in the red on Wednesday after a slew of weak economic reports weighed on the markets.
Acadia Healthcare (ACHC) Q4 Earnings Miss, Revenues Meet
by Zacks Equity Research
Acadia Healthcare (ACHC) Q4 earnings miss, down year over year on increase in expenses.
Community Health (CYH) Q4 Loss Wider Than Expected, Down Y/Y
by Zacks Equity Research
Community Health's (CYH) Q4 results disappoint with loss from decline in admissions, partially offset by lower expenses.
The Zacks Analyst Blog Highlights: Pepsico, Disney, Sanofi, Diageo and HCA
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Pepsico, Disney, Sanofi, Diageo and HCA
Top Research Reports for Pepsico, Walt Disney & Sanofi
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Pepsico (PEP), Walt Disney Company (DIS) and Sanofi (SNY).
Cigna's (CI) Q4 Earnings Miss, Revenues Surpass Estimates
by Zacks Equity Research
Cigna's (CI) Q4 earnings miss owing to a rise in expenses, which more than offset the increase in revenues.
Company News For Jan 30, 2019
by Zacks Equity Research
Companies In The News Are: HOG,XRX,PFE,HCA
HCA Healthcare's (HCA) Q4 Earnings Top Estimates, Surge Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings rise on the back of robust same facility admissions.
HCA Holdings (HCA) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 15.44% and 0.91%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
New Strong Buy Stocks for January 28th
by Nitish Marwah
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
HCA Holdings (HCA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, HCA Holdings (HCA) closed at $132.90, marking a +0.16% move from the previous day.
Will Lower Revenues Dampen Juniper's (JNPR) Q4 Earnings?
by Zacks Equity Research
Juniper (JNPR) is likely to report lower year-over-year revenues in Q4 due to challenges in the market, particularly within the cloud vertical.
Are Investors Undervaluing HCA Holdings (HCA) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will Top-Line Growth Support Corning's (GLW) Q4 Earnings?
by Zacks Equity Research
Corning (GLW) is likely to report higher year-over-year revenues in fourth-quarter 2018 on the back of healthy growth dynamics.
Is a Beat in Store for HCA Healthcare (HCA) Q4 Earnings?
by Zacks Equity Research
HCA Healthcare (HCA) is likely to gain from higher admissions in Q4 earnings.
New Strong Buy Stocks for January 24th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
Zacks.com featured expert Kevin Matras highlights: Boeing, HCA Healthcare, Lithia Motors, O'Reilly Automotive and UnitedHealth
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Boeing, HCA Healthcare, Lithia Motors, O'Reilly Automotive and UnitedHealth
Tap These 5 Stocks With Impressive Interest Coverage Ratio
by Zacks Equity Research
Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.
Bet on These 5 Low Leverage Stocks to Secure Returns
by Zacks Equity Research
A high degree of financial leverage means high interest payments, which affect the company's bottom line. So, investors try to avoid stocks that bear large debt loads
HCA Holdings (HCA) Is Up 4.66% in One Week: What You Should Know
by Zacks Equity Research
Does HCA Holdings (HCA) have what it takes to be a top stock pick for momentum investors? Let's find out.